ipamorelin and tesamorelin stack Can you CJC-1295, tesamorelin, together? Most clinics think CJC and work differently because they're marketed for separate benefits, but they're actually the same mechanism hitting identical receptors in stacking igf-1 lr3 with cjc-1295

PMID 8948633

High-dose use While trials have tested up to 1200mg/day (even as high as 2400mg/day) and illustrated safety, some report higher rates of gastrointestinal side effects, dizziness, and skin reactions at these levels.14 28 38 Additionally, these higher doses are often short-term (35 weeks) and used under clinical supervision

CV safety is currently under investigation for tirzepatide in patients with obesity without diabetes (NCT05556512) and for cagrilintide/semaglutide with overweight and obesity with and without diabetes (NCT05669755)

These elevations are generally harmless, as excess B12 is excreted renally